Vimarsana
Biggest News Aggregation in the World

Lawrence Blatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lawrence Blatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lawrence Blatt Today - Breaking & Trending Today

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD - Vimarsana News

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD - Vimarsana News

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in...

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects - Vimarsana News

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

SOUTH SAN FRANCISCO, Calif., April 03, 2024 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in...

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference - Vimarsana News

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

20.11.2023 - SOUTH SAN FRANCISCO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) - Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral ...

Aligos Therapeutics Shares Hit All-Time Low After Private Placement - Vimarsana News

Aligos Therapeutics Shares Hit All-Time Low After Private Placement

By Dean Seal Shares of Aligos Therapeutics hit an all-time low after the company struck a deal to raise about $92 million in a private placement. The stock...